The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Singh, A., Dilnawaz, F., Mewar, S., Sharma, U., Jagannathan, N. R., & Sahoo, S. K. (2011) · ACS Applied Materials & Interfaces · doi:10.1021/am101196v · Cited by 161
Self-citationRetractedParveen, S., Mitra, M., Krishnakumar, S., & Sahoo, S. K. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.02.010 · Cited by 63
Self-citationRetractedDas, M., & Sahoo, S. K. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.08.010 · Cited by 29
Self-citationRetractedBiodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Polymers at an interface; a simplified view
de Gennes, P. G. (1987) · Advances in Colloid and Interface Science · doi:10.1016/0001-8686(87)85003-0 · Cited by 1,679
PEGylated nanoparticles for biological and pharmaceutical applications
Otsuka, H., Nagasaki, Y., & Kataoka, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00226-0 · Cited by 1,588
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Self-citationThe present and future of nanotechnology in human health care
Sahoo, S. K., Parveen, S., & Panda, J. J. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.11.008 · Cited by 905
Self-citationSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
Gref, R., Domb, A., Quellec, P., Blunk, T., Müller, R. H., Verbavatz, J. M., & Langer, R. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00026-4 · Cited by 820
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery
Chan, J. M., Zhang, L., Yuet, K. P., Liao, G., Rhee, J.-W., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.013 · Cited by 702
Mohanty, C., & Sahoo, S. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.04.062 · Cited by 530
Self-citationChitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate
Wu, Y., Yang, W., Wang, C., Hu, J., & Fu, S. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.042 · Cited by 517
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Properties and biocompatibility of chitosan films modified by blending with PEG
Zhang, M., Li, X. H., Gong, Y. D., Zhao, N. M., & Zhang, X. F. (2002) · Biomaterials · doi:10.1016/s0142-9612(01)00403-3 · Cited by 484
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Self-citationCationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice.
Thurston, G., McLean, J. W., Rizen, M., Baluk, P., Haskell, A., Murphy, T. J., Hanahan, D., & McDonald, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci965 · Cited by 423
Sahoo, S. K., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050032z · Cited by 340
Self-citationTransmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
Self-citationSahoo, S. K., Ma, W., & Labhasetwar, V. (2004) · International Journal of Cancer · doi:10.1002/ijc.20405 · Cited by 327
Self-citationMacrophage Uptake of Core−Shell Nanoparticles Surface Modified with Poly(ethylene glycol)
Zahr, A. S., Davis, C. A., & Pishko, M. V. (2006) · Langmuir · doi:10.1021/la060951b · Cited by 324
Chitosan–PEG nanocapsules as new carriers for oral peptide delivery
Prego, C., Torres, D., Fernandez-Megia, E., Novoa-Carballal, R., Quiñoá, E., & Alonso, M. J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.015 · Cited by 308
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Self-citationHu, Y., Jiang, X., Ding, Y., Zhang, L., Yang, C., Zhang, J., Chen, J., & Yang, Y. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00021-8 · Cited by 261
Ligand-based targeted therapy for cancer tissue
Das, M., Mohanty, C., & Sahoo, S. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902780166 · Cited by 230
Self-citationIntracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 219
Self-citationSheng, Y., Liu, C., Yuan, Y., Tao, X., Yang, F., Shan, X., Zhou, H., & Xu, F. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.070 · Cited by 217
Avgoustakis, K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00224-2 · Cited by 211
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Quellec, P., Gref, R., Perrin, L., Dellacherie, E., Sommer, F., Verbavatz, J., & Alonso, M. J. (1998) · Journal of Biomedical Materials Research · Cited by 167
Sheng, Y., Yuan, Y., Liu, C., Tao, X., Shan, X., & Xu, F. L. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3746-9 · Cited by 159
Jain, D., & Banerjee, R. (2008) · Journal of Biomedical Materials Research Part B: Applied Biomaterials · doi:10.1002/jbm.b.30994 · Cited by 158
Capture of Stealth Nanoparticles by the Body’s Defences
Moghimi, S. M., & Hunter, A. C. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.30 · Cited by 154
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells
Thiele, L., Diederichs, J. E., Reszka, R. C., Merkle, H. P., & Walter, E. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00525-2 · Cited by 153
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.013 · Cited by 152
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150
Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor
Yang, R., Shim, W., Cui, F., Cheng, G., Han, X., Jin, Q., Kim, D., Chung, S., & Shim, C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.007 · Cited by 148
Yang, R., Yang, S., Shim, W., Cui, F., Cheng, G., Kim, I., Kim, D., Chung, S., & Shim, C. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21487 · Cited by 132
Prabha, S., & Labhasetwar, V. D. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049970+ · Cited by 128
Hu, F., Meng, P., Dai, Y.-Q., Du, Y., You, J., Wei, X.-H., & Yuan, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.015 · Cited by 104
Amiji, M. M. (1997) · Carbohydrate Polymers · doi:10.1016/s0144-8617(97)00006-4 · Cited by 97
Kim, S. M. (1995) · Polymer · doi:10.1016/0032-3861(95)96859-7 · Cited by 97
Mosqueira, V. C. F., Legrand, P., Gref, R., Heurtault, B., Appel, M., & BARRATT, G. M. (1999) · Journal of drug targeting · doi:10.3109/10611869909085493 · Cited by 92
Papisov, M. I. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00135-x · Cited by 90
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Small particles, big impacts: A review of the diverse applications of nanofluids
Taylor, R., Coulombe, S., Otanicar, T., Phelan, P., Gunawan, A., Lv, W., Rosengarten, G., Prasher, R., & Tyagi, H. (2013) · Journal of Applied Physics · doi:10.1063/1.4754271 · Cited by 759
PLGA: a Unique Polymer for Drug Delivery
Kapoor, D. N., Bhatia, A., Kaur, R., Sharma, R., Kaur, G., & Dhawan, S. (2015) · Therapeutic Delivery · doi:10.4155/tde.14.91 · Cited by 609
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Barriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Metadata
- Authors
- Parveen, S., & Sahoo, S. K.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 670
- Issue
- 2-3
- Pages
- 372-383
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2057876241
- Cited by
- 302
- References
- 50
- FWCI
- 6.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.